Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-12-06
1993-07-27
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514397, 514422, 546275, 548518, 5483147, A61K 3144, A61K 3140, C07D40112, C07D20710
Patent
active
052311066
ABSTRACT:
Novel O-alkylated oximes of the general formula I ##STR1## or ##STR2## wherein R.sup.1 and R.sup.2 are optionally substituted aromatic or heteroaromatic rings, R.sup.3 is hydrogen or lower alkyl, R.sup.4 is a nitrogen containing, substituted ring or an amino group carrying a substituted ring, and n and m independently are 0, 1 or 2, are potent inhibitors of GABA reuptake from the synaptic cleft.
REFERENCES:
patent: 4477453 (1984-10-01), Astoin
patent: 4772615 (1988-09-01), Pavia
patent: 5006560 (1991-04-01), Kreutner
Rossi et al., ".beta.-Dialkylaminoethylketoximes . . . ", CA 61: 10545g (1964).
Andersen Knud E.
Jorgensen Anker S.
Knutsen Lars J. S.
Sonnewald Ursula
Chang Celia
Hueschen Gordon W.
Ivy C. Warren
Novo Nordisk A S
LandOfFree
Azacyclic carboxylic acid derivatives and their preparation and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azacyclic carboxylic acid derivatives and their preparation and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azacyclic carboxylic acid derivatives and their preparation and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2342534